UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Fresenius Medical Care launches automatic peritoneal dialysis device
Fresenius Medical Care Korea said that it has launched Sleep•Safe Harm...
by Lee Han-soo
|
2019-07-24 14:44
라인
Two professors develop artificial esophagus through animal experiment
Korean researchers have developed artificial esophagi through a successful ...
by Choi Gwang-seok
|
2019-07-24 14:23
라인
Tecentriq 1st immunotherapy to get coverage regardless of PD-L1 expression
Roche said Tecentriq, its immunotherapy treatment, will receive reimburseme...
by Lee Han-soo
|
2019-07-24 11:59
라인
Korea to set aside ₩3.5 trillion to support new drug development
Government agencies related to new drug development have outlined the "Nati...
by Jeong Sae-im
|
2019-07-24 11:59
라인
OECD puts people at center of healthcare; assesses quality from patients’ viewpoint
It is often said that medical professionals should provide healthcare servi...
by Song Soo-youn
|
2019-07-23 16:55
라인
Alteogen to develop growth hormone for children with Brazilian partner
Alteogen said it has signed a licensing agreement with Cristalia, a Brazili...
by Lee Han-soo
|
2019-07-23 15:57
라인
Hanmi's US partner to expand Poziotinib clinical program
Spectrum Pharmaceuticals, Hanmi Pharmaceutical's U.S. partner, said tha...
by Lee Han-soo
|
2019-07-23 14:25
라인
'Hearing loss risk factor for cognitive impairment'
A research team at Chung-Ang University Hospital has found the mechanism be...
by Lee Han-soo
|
2019-07-23 12:54
라인
Regulator approves P3 trials for RSV treatment with extended half-life
Phase 3 clinical trials of Nirsevimab, a treatment for the respiratory sync...
by Lee Hye-seon
|
2019-07-23 11:08
라인
Merck Biopharma Korea names new general manager
Merck Korea said that it has appointed Javed Alam as the new general manage...
by Lee Han-soo
|
2019-07-23 11:08
라인
‘Doubts about biopharmaceutical-developing ability to change investment pattern’
Korea Investment & Securities said that it expects the investment sentiment...
by By Jeong Sae-im
|
2019-07-23 10:58
라인
Physicians hit street to demand special law for medical accidents
About 400 physicians protested against a court ruling, holding pickets that...
by Song Soo-youn
|
2019-07-22 18:27
라인
Korean visit hospitals most frequently in OECD despite fewest physicians
Korea showed mixed results in the 2019 Organization for Economic Cooperatio...
by Lee Han-soo
|
2019-07-22 17:36
라인
Will Gilead enter the autoimmune diseases market?
Gilead Sciences is highly likely to buy Otezla (apremilast), a new oral PDE...
by Kim Yun-mi
|
2019-07-22 17:34
라인
Korean drugs strong in anti-reflux treatment market
Locally developed drugs are showing robust sales records in gastroesophagea...
by Jeong Sae-im
|
2019-07-22 15:15
라인
Celltrion Healthcare joins Australia's pharma industry group
Celltrion Healthcare said that it has joined Australia's Generic and Bi...
by Lee Han-soo
|
2019-07-22 15:13
라인
‘Treatment of atrial fibrillation can improve cognitive functions’
Researchers at Severance Hospital have found that the treatment of heart di...
by Lee Han-soo
|
2019-07-22 15:12
라인
JW completes P1 trials for target anticancer treatment
JW Pharmaceuticals said that it has presented phase 1a/1b clinical trial re...
by Lee Han-soo
|
2019-07-22 14:02
라인
Samsung BioLogics’ fate remains uncertain amid litigating ups and downs
The accounting fraud allegation involving Samsung BioLogics has been one of...
by Lee Han-soo
|
2019-07-19 18:16
라인
Watson exposes Korean healthcare system’s limitation
#Tragedy struck Mr. A all of a sudden. He visited a hospital thinking it wo...
by Song Soo-youn
|
2019-07-19 17:48
-
이전
101
102
103
104
105
106
107
108
109
110
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top